Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2026
Pembrolizumab and Paclitaxel in HR+/HER2- Breast Cancer with HER2-Enriched or Basal-Like Subtypes
Benedetta Conte, Fara Brasó-Maristany, Tomás Pascual, et al.
Ebiomedicine
|
March 6, 2024
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies
Benedetta Conte, Fara Brasó-Maristany, Adela Rodríguez Hernández, et al.
Clinical Colorectal Cancer
|
July 3, 2024
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer
Alberto Hernando-Calvo, Ming Han, Olubukola Ayodele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO Study
Maria Alsina, Guillermo Villacampa, Carlos de Andrea, et al.
Cancer Discovery
|
September 13, 2023
Early-Stage Breast Cancer Detection in Breast Milk
Cristina Saura, Carolina Ortiz, Judit Matito, et al.
Ebiomedicine
|
January 6, 2022
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
Aleix Prat, Valentina Guarneri, Tomás Pascual, et al.
Journal of Personalized Medicine
|
December 29, 2022
Laboratory Cross-Comparison and Ring Test Trial for Tumor <i>BRCA</i> Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola, et al.
JCO Precision Oncology
|
August 23, 2024
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab
Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, et al.
Cell Reports. Medicine
|
February 6, 2025
Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence
Sara Arce-Gallego, Pablo Cresta Morgado, Luisa Delgado-Serrano, et al.
Oncotarget
|
April 21, 2017
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer
Aranzazu Fernandez-Martinez, Tomás Pascual, Giuseppe Perrone, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2026
Pembrolizumab and Paclitaxel in HR+/HER2- Breast Cancer with HER2-Enriched or Basal-Like Subtypes
Benedetta Conte, Fara Brasó-Maristany, Tomás Pascual, et al.
Ebiomedicine
|
March 6, 2024
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies
Benedetta Conte, Fara Brasó-Maristany, Adela Rodríguez Hernández, et al.
Clinical Colorectal Cancer
|
July 3, 2024
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer
Alberto Hernando-Calvo, Ming Han, Olubukola Ayodele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO Study
Maria Alsina, Guillermo Villacampa, Carlos de Andrea, et al.
Cancer Discovery
|
September 13, 2023
Early-Stage Breast Cancer Detection in Breast Milk
Cristina Saura, Carolina Ortiz, Judit Matito, et al.
Ebiomedicine
|
January 6, 2022
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
Aleix Prat, Valentina Guarneri, Tomás Pascual, et al.
Journal of Personalized Medicine
|
December 29, 2022
Laboratory Cross-Comparison and Ring Test Trial for Tumor <i>BRCA</i> Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola, et al.
JCO Precision Oncology
|
August 23, 2024
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab
Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, et al.
Cell Reports. Medicine
|
February 6, 2025
Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence
Sara Arce-Gallego, Pablo Cresta Morgado, Luisa Delgado-Serrano, et al.
Oncotarget
|
April 21, 2017
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer
Aranzazu Fernandez-Martinez, Tomás Pascual, Giuseppe Perrone, et al.
Page
of 11